» Articles » PMID: 28981081

Influence of GABA-B Agonist Baclofen on Capsaicin-Induced Excitation of Secondary Peristalsis in Humans

Overview
Specialty Gastroenterology
Date 2017 Oct 6
PMID 28981081
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Esophageal instillation of capsaicin enhances secondary peristalsis, but the γ-aminobutyric acid receptor type B (GABA-B) agonist baclofen inhibits secondary peristalsis. This study aimed to investigate whether baclofen could influence heartburn perception and secondary peristalsis subsequent to capsaicin infusion in healthy adults.

Methods: Secondary peristalsis was performed by slow and rapid mid-esophagus air injections in 15 healthy subjects. Two different sessions including esophageal infusion of capsaicin-containing red pepper sauce (0.84 mg) following pre-treatment with placebo or baclofen were randomly performed to test the effects on heartburn perception and secondary peristalsis.

Results: The intensity of heartburn symptom subsequent to capsaicin infusion was significantly greater after pre-treatment of baclofen as compared with the placebo (P=0.03). Baclofen significantly increased the threshold volume of secondary peristalsis to slow air injections subsequent to esophageal capsaicin infusion (P<0.001). Baclofen significantly increased the threshold volume of secondary peristalsis to rapid air injections subsequent to esophageal capsaicin infusion (P<0.01). The frequency of secondary peristalsis subsequent to capsaicin infusion was significantly decreased with baclofen as compared with the placebo (P<0.002). Baclofen had no effect on any of the peristaltic parameters of secondary peristalsis subsequent to capsaicin infusion.

Conclusions: The GABA-B agonist baclofen appears to attenuate the esophagus to capsaicin-induced excitation of secondary peristalsis in healthy adults. Our study suggests the inhibitory modulation for GABA-B receptors on capsaicin-sensitive afferents mediating secondary peristalsis in human esophagus.

Citing Articles

New Developments in the Diagnosis and Management of Gastroesophageal Reflux.

Jiang Y, Clarke J Curr Treat Options Gastroenterol. 2020; 18(1):69-81.

PMID: 32072470 DOI: 10.1007/s11938-020-00275-1.


Baclofen and gastroesophageal reflux disease: seeing the forest through the trees.

Clarke J, Fernandez-Becker N, Regalia K, Triadafilopoulos G Clin Transl Gastroenterol. 2018; 9(3):137.

PMID: 29599487 PMC: 5876385. DOI: 10.1038/s41424-018-0010-y.

References
1.
Brooks P, Glaum S, Miller R, Spyer K . The actions of baclofen on neurones and synaptic transmission in the nucleus tractus solitarii of the rat in vitro. J Physiol. 1992; 457:115-29. PMC: 1175720. DOI: 10.1113/jphysiol.1992.sp019367. View

2.
Sifrim D, Zerbib F . Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012; 61(9):1340-54. DOI: 10.1136/gutjnl-2011-301897. View

3.
Chen C, Liu T, Yi C, Orr W . Effects of capsaicin-containing red pepper sauce suspension on esophageal secondary peristalsis in humans. Neurogastroenterol Motil. 2010; 22(11):1177-82, e312-3. DOI: 10.1111/j.1365-2982.2010.01561.x. View

4.
Janssens J, Valembois P, VANTRAPPEN G, Hellemans J, Pelemans W . Is the primary peristaltic contraction of the canine esophagus bolus-dependent?. Gastroenterology. 1973; 65(5):750-6. View

5.
Bolser D, Aziz S, DeGennaro F, Kreutner W, Egan R, Siegel M . Antitussive effects of GABAB agonists in the cat and guinea-pig. Br J Pharmacol. 1993; 110(1):491-5. PMC: 2175970. DOI: 10.1111/j.1476-5381.1993.tb13837.x. View